Resmed Inc. buy Citigroup Inc.
Start price
09.04.26
/
50%
€194.95
Target price
09.04.27
€291.55
Performance (%)
-12.77%
Price
05.06.26
€170.05
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -12.77%. This prediction currently runs until 09.04.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 4.038% | 4.038% |
| iShares Core DAX® | -1.862% | 0.670% |
| iShares Nasdaq 100 | -3.322% | 4.989% |
| iShares Nikkei 225® | -2.299% | 6.129% |
| iShares S&P 500 | -1.313% | 3.399% |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (RMD) had its price target lowered by Citigroup Inc. from $345.00 to $340.00. They now have a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat